Literature DB >> 26253745

Improved glycemic control in veterans with poorly controlled diabetes mellitus using a Specialty Care Access Network-Extension for Community Healthcare Outcomes model at primary care clinics.

Sharon A Watts1, Laura Roush2, Mary Julius3, Ajay Sood4.   

Abstract

INTRODUCTION: An increasing number of patients with diabetes mellitus has created a need for innovative delivery of specialized care not only by diabetes specialists but also by primary care providers (PCPs) as well. A potential avenue to address this need is training of PCPs by specialists via telehealth. The Veteran Affairs (VA) Specialty Care Access Network-Extension for Community Healthcare Outcomes (SCAN-ECHO) program includes education and case-based learning for PCPs by a multidisciplinary specialty team utilizing videoconferencing technology.
METHODS: Two PCPs completed a year of SCAN-ECHO diabetes training. These two PCPs set up "diabetes mini-clinics" to treat difficult-to-control high-risk patients with diabetes mellitus from their own panel and from their colleagues in the same community-based outpatient clinic (CBOC). We utilized a retrospective program evaluation by t-test using pre/post glycated hemoglobin (HbA1c) lab values after being seen by the two PCPs.
RESULTS: A total of 39 patients, all with HbA1c > 9.0%, were seen in the two PCP mini-clinics over 15 months. The mean HbA1c improved from 10.2 ± 1.4% to 8.4 ± 1.8% (p < 0.001) over the average follow-up period of five months. This was not explained by system-wide changes or improvements. DISCUSSION: Care of veteran patients with poorly controlled diabetes by PCPs who participated in SCAN-ECHO program leads to improvement in glycemic control. This model of health care delivery can be effective in remote or rural areas with limited availability of specialists.
© The Author(s) 2015.

Entities:  

Keywords:  Diabetes; primary care; quality improvement

Mesh:

Substances:

Year:  2015        PMID: 26253745     DOI: 10.1177/1357633X15598052

Source DB:  PubMed          Journal:  J Telemed Telecare        ISSN: 1357-633X            Impact factor:   6.184


  7 in total

Review 1.  Redesigning Diabetes Care: Defining the Role of Endocrinologists Among Alternative Providers.

Authors:  Samir Malkani; Sheri A Keitz; David M Harlan
Journal:  Curr Diab Rep       Date:  2016-12       Impact factor: 4.810

2.  Direct and Indirect Effects of a Project ECHO Longitudinal Clinical Tele-Mentoring Program on Viral Suppression for Persons With HIV: A Population-Based Analysis.

Authors:  Brian R Wood; Karin Bauer; Richard Lechtenberg; Susan E Buskin; Lea Bush; Jeff Capizzi; Beth Crutsinger-Perry; Steven J Erly; Timothy W Menza; Jennifer R Reuer; Matthew R Golden; James P Hughes
Journal:  J Acquir Immune Defic Syndr       Date:  2022-08-15       Impact factor: 3.771

3.  Comparison of Satisfaction With Comorbid Depression Care Models Among Low-Income Patients With Diabetes.

Authors:  Olivia Evanson; Shinyi Wu
Journal:  J Patient Exp       Date:  2019-10-31

4.  Impact of Project ECHO Models of Medical Tele-Education: a Systematic Review.

Authors:  Ryan K McBain; Jessica L Sousa; Adam J Rose; Sangita M Baxi; Laura J Faherty; Caroline Taplin; Andre Chappel; Shira H Fischer
Journal:  J Gen Intern Med       Date:  2019-09-04       Impact factor: 5.128

5.  Impact of a Provider Tele-mentoring Learning Model on the Care of Medicaid-enrolled Patients With Diabetes.

Authors:  Joel C Cantor; Sujoy Chakravarty; Jennifer Farnham; Jose Nova; Sana Ahmad; James H Flory
Journal:  Med Care       Date:  2022-02-22       Impact factor: 3.178

6.  Interactive Video Telehealth Models to Improve Access to Diabetes Specialty Care and Education in the Rural Setting: A Systematic Review.

Authors:  Susan Florence McLendon
Journal:  Diabetes Spectr       Date:  2017-05

7.  Evaluation of the effects of a diabetes educational program: a randomized clinical trial.

Authors:  Heloísa de Carvalho Torres; Ana Emília Pace; Fernanda Figueredo Chaves; Gustavo Velasquez-Melendez; Ilka Afonso Reis
Journal:  Rev Saude Publica       Date:  2018-02-05       Impact factor: 2.106

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.